⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a
very recent recall may be missing. Everything shown is accurate as of the last checked time on this page —
for anything time-critical, confirm with the official sources linked below.
FDAClass III · Drug · Recalled May 27, 2026
Primidone Tablets recall — Golden State Medical Supply Inc.
Hazard: Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Class III: not likely to cause adverse health consequences.
View the official FDA enforcement record (openFDA) ↗
- Official recall ID
- D-0534-2026
- Brand
- Golden State Medical Supply
- Classification
- Class III
- Units affected
- 8,526 bottles
- Recall status
- Ongoing
- Initiated
- Voluntary: Firm initiated
Description
Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Incorporated, Camarillo, CA 93012. NDC 51407-637-05
Affected products
Companies & origin
- Recalling firm location
- Camarillo, CA, United States
- Firm address
- 5187 Camino Ruiz, 93012-8601
Identifying details (verbatim from the notice)
- Product codes / lots
- Lot#: GS066750, GS067084, GS067710, GS067873, Exp 3/31/2028; GS068339, GS068897, Exp 8/31/2028
- Distribution
- USA Nationwide
- Firm notified the public via
- Letter
- FDA event ID
- 98856
- Recall initiated
- April 27, 2026
- FDA classified
- May 18, 2026
- FDA report date
- May 27, 2026
Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim;
the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.
Report a data error on this page